Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory
infection, lower respiratory tract disease, clinical complications, and death in older adults. There …

These clinical practice guidelines are an update of the guidelines published by the Infectious
Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. …

Background The coronavirus disease 2019 (COVID-19) pandemic has led to significant
reductions in transplantation, motivated in part by concerns of disproportionately more severe …

Adenoviruses are increasingly recognized as contributors to morbidity and mortality among
stem cell and solid-organ transplant recipients. Clinical presentations range from …

The chr12q24.13 locus encoding OAS1–OAS3 antiviral proteins has been associated with
coronavirus disease 2019 (COVID-19) susceptibility. Here, we report genetic, functional and …

Methods Prior to the conference, the organizing committee identified topics relevant to the
management of patients with ACLF. A diverse international panel representing multiple …

Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient-…

Influenza virus with resistance to antiviral drugs emerges with increased frequency in
immunocompromised patients and can limit the benefit of M2 and neuraminidase (NA) inhibitors. …

Tuberculosis (TB) is a possible complication of solid organ and hematopoietic stem cell
transplantation. The identification of candidates for preventive chemotherapy is an effective …

Background Baloxavir marboxil (hereafter baloxavir), a selective inhibitor of influenza cap-dependent
endonuclease, was approved in 2018 in the USA and Japan for the treatment of …